Hergen expands its presence in Europe’s Tissue machine market

Written on 10/02/2026
Stephane RICHARD


Three Tissue machines. Three projects in Europe. And a new chapter in Hergen’s international journey.

At MIAC 2026, Hergen invites Tissue producers, customers and industry professionals to visit Stand C16 and learn more about the projects that are strengthening the company’s presence in the European market.

According to the Tissue World Magazine Survey Report, March/April 2026, 11 Tissue machine projects are under execution in Europe for the 2026–2027 period.

Three of these projects are being supplied by Hergen — representing 27.3% of the projects identified in the survey.

The three projects are being delivered by Hergen during 2026, with start-ups scheduled for 2027. In addition to representing an important moment for the company’s presence in the Tissue market, these projects are part of a broader international track record.

Over the past 15 years, Hergen has supplied 11 projects to Europe. Now, three new Tissue projects under execution in the region are adding to this track record and further strengthening the company’s presence in the European market.

The timing is particularly significant: while Hergen reaches 11 projects supplied to Europe over its 15-year track record, the European Tissue market is also seeing 11 projects under execution for 2026–2027, according to the Tissue World Magazine survey.

But the numbers are only part of the story.

What are Hergen’s three projects? Which technologies are being supplied? And what do these projects mean for European producers considering new Tissue capacity investments?

These are some of the topics the Hergen team will be ready to discuss at MIAC 2026 — Stand C16.

Meet the Hergen team, talk about your next project and discover more about the Tissue machines currently being delivered in Europe.

📍 Hergen — Stand C16

🎟️ Free registration

Let’s talk Tissue.

Source: Tissue World Magazine, Survey Report, March/April 2026.